Close

Endo (ENDP) Target Raised to $110 at Piper Jaffray as Physician Survey Bodes Well For Belbuca Uptake

April 16, 2015 7:01 AM EDT Send to a Friend
Piper Jaffray analyst David Amsellem reiterated an Overweight rating and boosted his price target on Endo International plc (NASDAQ: ENDP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login